Rhythm Pharmaceuticals, Inc.· RYTM

🇺🇸 US · MidBroad USNASDAQ

Healthcare Biotechnology Website

Price: $97.71
Day: -1.32%
Mkt Cap: $6.70B
52W Range: $74.50 – $122.20
Volume: 1.12M
Beta: 1.97

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Peer Comparison: 2.3 / 5 (Weak) against 136 sector peers in United States · Mid Cap · Healthcare
Pillars: strongest Leverage & Coverage 4.0, weakest Valuation Multiples 1.0 (10 of 10 ranked)
Ranks: ROIC 5th percentile, operating margin 3rd percentile

Blog

stockoscope.com

Rhythm Pharmaceuticals, Inc.

RYTM|Healthcare|Biotechnology

Comparing against 136 sector peers in United States · Mid Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

85%ile

53.5%

Operating Margin

3%ile

-83.6%

ROIC

5%ile

-63.8%

FCF Yield

37%ile

-2.3%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

15.7%

EBIT Growth

15.3%

Net Income Growth

12.2%

OCF Growth

38.8%

FCF Growth

39.7%

Income Quality

0.57

Returns on Capital (TTM)

ROE(-80.5%)

9%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-64.0%)

5%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROA(-47.0%)

6%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(-63.8%)

5%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(89.0%)

90%ile

Top 20%

PoorWeakAdequateStrongExceptional

EBITDA Margin(-77.0%)

4%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Operating Margin(-83.6%)

3%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Net Margin(-85.6%)

4%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

81%ile

0.02

Debt/Capital

81%ile

0.02

Net Debt/EBITDA

65%ile

0.34

Interest Coverage

21%ile

-10.86x

Liquidity (TTM)

Current Ratio

36%ile

3.45

Quick Ratio

41%ile

3.20

Cash Ratio

16%ile

0.53

WC Turnover

47%ile

0.76

Operational Efficiency (TTM)

Asset Turnover

50%ile

0.55

DSO

36%ile

61.5

Days Inventory

7%ile

422

Cash Conv. Cycle

16%ile

260

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore RYTM on stockoscope.com→

Generated September 21, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

136 sector peers (United States · Mid Cap · Healthcare)

Relative Quality

RYTM Relative Quality Score

Ranked against 136 sector peers in United States · Mid Cap · Healthcare

Relative Quality

2.3/5

Weak

vs 136 sector peers

Peer Rankings (10 of 10 available)

Relative Quality Score of 2.28/5 (Weak) based on percentile rankings against 136 sector peers in United States · Mid Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated September 20, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

85th percentile, Exceptional

Value: 53.51%
Percentile: 85%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm revenue growth of 53.51% and ranks at the 85th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

Gross Margin

90th percentile, Exceptional

Value: 89.00%
Percentile: 90%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm gross margin of 89.00% and ranks at the 90th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

50th percentile, Adequate

Value: 0.55
Percentile: 50%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm asset turnover of 0.55 and ranks at the 50th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

6th percentile, Poor

Value: -46.96%
Percentile: 6%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm roa of -46.96% and ranks at the 6th percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

72nd percentile, Strong

Value: 38.81%
Percentile: 72%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm operating cash flow growth of 38.81% and ranks at the 72nd percentile vs United States · Healthcare sector peers. Strong financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

16th percentile, Poor

Value: 0.53
Percentile: 16%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm cash ratio of 0.53 and ranks at the 16th percentile vs United States · Healthcare sector peers. Poor financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

81st percentile, Exceptional

Value: 0.02
Percentile: 81%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm debt-to-capital of 0.02 and ranks at the 81st percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -31.42
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank RYTM for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

Dividend Yield

31st percentile, Weak

Value: 0.00%
Percentile: 31%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

RYTM has a ttm dividend yield of 0.00% and ranks at the 31st percentile vs United States · Healthcare sector peers. Below average financial performance.

Peer companies

The 136 companies RYTM is compared against across its sector and industry cohorts.

Rhythm Pharmaceuticals, Inc.· RYTM

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies